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Abstract
Metazoan development is regulated by transcriptional networks,
which must respond to extracellular cues including cytokines. The
JAK/STAT pathway is a highly conserved regulatory module, acti-
vated by many cytokines, in which tyrosine-phosphorylated STATs
(pSTATs) function as transcription factors. However, the mecha-
nisms by which STAT activation modulates lineage-affiliated tran-
scriptional programs are unclear. We demonstrate that in the
absence of thrombopoietin (TPO), tyrosine-unphosphorylated
STAT5 (uSTAT5) is present in the nucleus where it colocalizes with
CTCF and represses a megakaryocytic transcriptional program.
TPO-mediated phosphorylation of STAT5 triggers its genome-wide
relocation to STAT consensus sites with two distinct transcriptional
consequences, loss of a uSTAT5 program that restrains mega-
karyocytic differentiation and activation of a canonical pSTAT5-driven
program which includes regulators of apoptosis and proliferation.
Transcriptional repression by uSTAT5 reflects restricted access of
the megakaryocytic transcription factor ERG to target genes. These
results identify a previously unrecognized mechanism of cytokine-
mediated differentiation.
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Introduction
Metazoan development is controlled by complex gene regulatory
networks that need to respond rapidly to extracellular signals
(Davidson, 2006, 2010). The JAK/STAT signaling pathway is essential
for normal development and adult homeostasis in organisms from
C. elegans to mammals (Stark & Darnell, 2012; Wang & Levy, 2012).
Following their interaction with cellular receptors, many cytokines
and other growth factors trigger rapid activation of JAK family kinases
with consequent tyrosine phosphorylation and activation of STATs.
Activated STATs (pSTATs) accumulate in the nucleus, bind to DNA,
and regulate the transcription of target genes (Levy & Darnell, 2002).
Hematopoiesis is regulated by multiple cytokines which activate
the JAK/STAT pathway (Metcalf, 2008) and also by combinatorial
transcription factor interactions that establish cell-type specific
patterns of gene expression (Orkin & Zon, 2008). However, the
mechanisms by which lineage-affiliated transcriptional programs are
modulated by JAK/STAT activation remain obscure. Non-canonical
modes of JAK/STAT signaling have been described and include the
demonstration that JAK2 functions in the nucleus as a histone kinase
(Dawson et al, 2009, 2012; Griffiths et al, 2011), that JAK/STAT
signaling in Drosophila disrupts heterochromatin (Shi et al, 2006,
2008), and that overexpressed STAT mutants that cannot be tyrosine-
phosphorylated can act as transcription factors with the best-studied
examples coming from STAT1 and STAT3 (Chatterjee-Kishore et al,
2000; Yang et al, 2005, 2007; Cui et al, 2007; Cheon et al, 2011).
However, none of these insights have linked JAK/STAT activation to
the transcriptional networks that control hematopoiesis, and we
currently lack a genome-wide understanding of the biological role of
any tyrosine-unphosphorylated STAT (uSTAT).
STAT5 exists as 2 isoforms (STAT5A and STAT5B with 95%
amino acid identity) encoded by two closely linked genes
(Hennighausen & Robinson, 2008) that are essential for normal
organogenesis (Teglund et al, 1998; Cui et al, 2004), hematopoiesis,
and lymphopoiesis (Hoelbl et al, 2006; Yao et al, 2006). Overexpres-
sion of constitutively active STAT5A gives rise to multilineage
leukemia (Kato et al, 2005; Moriggl et al, 2005), hematopoietic stem
and progenitor cell (HSPC) expansion, and enhanced erythropoiesis
(Schuringa et al, 2004). Within hematopoiesis, the two isoforms are
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largely redundant (Liu et al, 1997; Udy et al, 1997), widely
expressed, and frequently referred to collectively as STAT5. Dif-
ferent cytokines activate STAT5 in distinct cell types (Schepers et al,
2012). In HSPC and within the megakaryocytic lineage, STAT5 is
activated by thrombopoietin (TPO) (Kirito & Kaushansky, 2006;
Vainchenker & Constantinescu, 2013) which, together with its
receptor MPL, is essential for normal megakaryopoiesis (Gurney
et al, 1994; Alexander et al, 1996; de Sauvage et al, 1996; Bunting
et al, 1997) and normal hematopoietic stem cell (HSC) behavior
(Alexander et al, 1996; Solar et al, 1998; Fox et al, 2002; Yoshihara
et al, 2007). However, little is known about the way in which the
consequences of cytokine-induced STAT5 activation are integrated
with any lineage-affiliated transcriptional program. Genome-wide
analyses have focused on the role of activated pSTAT5 (Yang et al,
2011; Dawson et al, 2012; Zhu et al, 2012; Kang et al, 2013), and a
general problem for understanding the biology of endogenous
uSTAT5 (and all uSTATs) has been the lack of cellular systems in
which uSTAT function can be studied separately from the corre-
sponding pSTAT.
Results
uSTAT5 is present in the nucleus of hematopoietic stem/
progenitor cells
To investigate potential functions for uSTAT5 in hematopoietic
stem/progenitor cells, we first explored the subcellular localization
of STAT5 proteins in primary LinSca-1+cKit+ (LSK) cells isolated
from mouse bone marrow. Using an antibody detecting tyrosine-
phosphorylated STAT5 (both Tyr 694 in STAT5a and Tyr 699 in
STAT5b, henceforth termed pSTAT5), pSTAT5 was weakly detect-
able in the nuclei of freshly isolated cells, became undetectable after
4 h of serum starvation, and was rapidly induced following TPO
stimulation (Fig 1A). By contrast, using an antibody that detects
total STAT5 protein, nuclear STAT5 was readily detectable under all
three conditions (Fig 1A). These results were confirmed using
confocal imaging (Fig EV1A) and indicate the presence of nuclear
STAT5 proteins that lack tyrosine phosphorylation (uSTAT5).
We then established an experimental system that would allow
separate functional analysis of uSTAT5 and pSTAT5. HPC7
hematopoietic stem/progenitor cells are cytokine dependent, multi-
potent, and karyotypically normal (Pinto do et al, 1998). HPC7 cells
self-renew in the presence of SCF, but undergo megakaryocytic
differentiation following TPO stimulation (Figs 1B and EV1B–D)
(Dumon et al, 2012). We found that TPO robustly induces pSTAT5
in HPC7 cells. Interestingly, however, pSTAT5 disappeared within
hours, suggesting that sustained pSTAT5 may not be required for
megakaryocyte differentiation in this model (Fig EV1E). Under self-
renewal conditions, pSTAT5 was not detectable in either cytoplas-
mic or nuclear fractions, whereas an antibody to total STAT5 readily
detected STAT5 protein in both compartments (Fig 1C, lanes 1 and
2). Even after the removal of both SCF and serum, nuclear STAT5
remained evident in the absence of detectable pSTAT5 (Fig 1D, lane
1). The subsequent addition of TPO resulted in rapid accumulation
of nuclear pSTAT5 (Fig 1D). We considered the possibility that even
in the absence of SCF and serum, cells might, nonetheless, harbor
low levels of nuclear pSTAT5, below the detection threshold for
Western blotting. However, sequential immunoprecipitation of total
nuclear STAT5 proteins followed by Western blotting also failed to
detect any pSTAT5 in unstimulated cells (Fig 1E, lane 4). Together,
these results demonstrate that hematopoietic stem/progenitor cells
contain nuclear STAT5 in the absence of detectable pSTAT5 and
that HPC7 cells provide a powerful system for dissecting the distinct
functions of uSTAT5 and pSTAT5.
TPO stimulation results in genome-wide redistribution of STAT5
from CTCF to STAT-binding sites
To compare the genomic localization of uSTAT5 and pSTAT5, chro-
matin immunoprecipitation coupled with high-throughput DNA
sequencing (ChIP-Seq) was performed using unstimulated
(T = 0 min) and TPO-treated (T = 30 min) HPC7 cells, respectively.
Significant binding events in comparison with control IgG samples
were identified using the MACS algorithm (Zhang et al, 2008).
Using an antibody against total STAT5, we observed a striking redis-
tribution of STAT5 peaks following TPO stimulation (Fig 2A and B).
Three distinct clusters of STAT5 peaks were identified. Cluster 1
(4,109 elements) contained peaks present only in unstimulated cells
and which therefore represent binding of uSTAT5; this cluster
contained multiple genes associated with megakaryocytic differenti-
ation (e.g., Mpl, Gp6, Pf4, and Cd41; Figs 2B and EV2A). Cluster 2
(771 elements) contained peaks present only in TPO-treated cells
and which were therefore likely to represent binding of pSTAT5;
this cluster included multiple known STAT target genes (e.g., Cish,
Bcl6, Pim2, and Socs2, Figs 2B and EV2B). Cluster 3 (198 elements)
contained those peaks that were unchanged by TPO treatment. The
genomic distribution of STAT5 under those two conditions was also
different with a 3-fold enrichment of STAT5 binding in promoter
regions in unstimulated cells compared to TPO-stimulated cells
(T = 0 versus T = 30, Fig EV2C). We validated ChIP-Seq data by
ChIP-qPCR using antibodies to total STAT5 or pSTAT5. STAT5 bind-
ing was confirmed at all 6 target sites examined (Fig 2C and D) and,
as expected, pSTAT5 binding was only detectable following TPO
stimulation (Fig 2C and D). These results demonstrate that in
unstimulated cells, uSTAT5 binds to regions that are completely dif-
ferent to those bound by pSTAT5 following TPO stimulation.
To investigate whether the STAT5 redistribution occurs in a
sequence-specific manner, DNA sequences associated with STAT5
peaks were analyzed using MEME (Bailey et al, 2009). As expected,
the most enriched motif in TPO-stimulated cells (containing
pSTAT5) was a STAT consensus-binding site or GAS motif (Fig 2E
and Appendix Table S1). In marked contrast, the most enriched
motif in unstimulated cells (containing only uSTAT5) was a CTCF-
binding site (Fig 2E and Appendix Table S1), which was centrally
located within regions bound by STAT5 (Fig EV2D). Our STAT5
ChIP-Seq results were then compared to previously reported CTCF
ChIP-Seq data in HPC7 cells (Calero-Nieto et al, 2014). Approxi-
mately two-thirds (64%) of the uSTAT5 peaks present in unstimu-
lated cells colocalized with CTCF peaks, and the vast majority (97%)
of these STAT5 peaks were lost following TPO treatment (Figs 2F
and G, and EV2E). To exclude the possibility that the STAT5 antibody
recognizes non-specific proteins, we tested antibody specificity using
Western blotting and immunofluorescence assays on STAT5-null
MEFs. The absence of immunoreactivity in STAT5-null samples
clearly demonstrates that the STAT5 antibody used in this study is
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Figure 1. STAT5 proteins localize to the nucleus in the absence of tyrosine phosphorylation.
A Immunofluorescence staining of LinSca-1+cKit+ (LSK) cells using an antibody specific for phosphorylated STAT5 (pSTAT5) or total STAT5. Scale bars represent 5 lm.
Bar graphs showing the quantification of nuclear localization presented as mean fluorescence intensity (MFI). Data are shown as means  SD of three independent
experiments. Two-tailed Student’s t-test, ***P < 0.001.
B Diagram showing HPC7 cells that self-renew in the presence of stem cell factor (SCF) and undergo megakaryocytic differentiation in response to thrombopoietin
(TPO).
C Western blot analysis of HPC7 cells grown in the presence of SCF demonstrates nuclear and cytoplasmic uSTAT5 in the absence of pSTAT5. K562 cell lysates were used
as a positive control for pSTAT5.
D Western blot analysis of HPC7 cells after TPO stimulation (100 ng/ml) at the indicated time points.
E Western blot analysis was performed after immunoprecipitation of STAT5 from unstimulated and TPO-stimulated cells using antibodies to total STAT5 or to pSTAT5
(pY694/p699). 1% (5 lg) of lysate was loaded as input control.
Source data are available online for this figure.
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Figure 2.
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specific to STAT5 proteins (Fig 2H and I). Together, these results
demonstrate that TPO stimulation is accompanied by a striking
redistribution of STAT5 binding with the loss of uSTAT5 binding to
CTCF sites and the recruitment of pSTAT5 to consensus STAT sites.
uSTAT5 represses a transcriptional program associated
with megakaryopoiesis
To explore the biological significance of the genomic regions bound
by both uSTAT5 and CTCF, we used the GREAT program (McLean
et al, 2010). GREAT analysis for the 2,723 regions bound by
uSTAT5 and CTCF revealed strong enrichment for genes associated
with hematopoiesis, especially megakaryocyte and platelet develop-
ment, whereas the 994 regions bound by pSTAT5 were enriched for
a variety of immunological functions (Fig EV3A).
To further investigate the transcriptional consequences of
uSTAT5 binding, shRNA-mediated STAT5 knockdown was
performed in self-renewing HPC7 cells, which do not express detect-
able level of pSTAT5 (Figs 1C and 3A). Two different shRNA
constructs markedly reduced levels of total STAT5 (Fig 3A) together
with protein and transcript levels of STAT5B, but not STAT5A
(Fig EV3B and C), indicating that STAT5B is the major STAT5
protein expressed in HPC7 cells. Knockdown of STAT5 resulted in
differential expression of 1,029 genes (367 upregulated; 662 down-
regulated; FDR <0.001; fold change >1.5). Of note, we observed no
significant change in the transcript levels of the canonical STAT5
target genes, including Cish and Socs2, indicating that these changes
observed are a consequence of depleting uSTAT5.
Several complementary lines of evidence indicate that uSTAT5
depletion resulted in upregulation of a transcriptional program
associated with megakaryopoiesis. (i) Of the 40 most highly upregu-
lated genes following STAT5 knockdown, at least 23 genes are
reported to be highly expressed in megakaryocytes and platelets
(Fig 3B). (ii) Gene set enrichment analysis (GSEA) using microarray
data for distinct hematopoietic progenitors (Pronk et al, 2007)
showed that genes upregulated by uSTAT5 knockdown were signifi-
cantly enriched in megakaryocytic progenitors (Fig 3C), whereas
downregulated genes were more highly expressed in common
lymphoid progenitors or pre-granulocyte/monocyte progenitors
(Fig EV4A). (iii) Gene ontology (GO) analysis showed that tran-
scripts upregulated by uSTAT5 depletion were enriched in genes
involved in blood coagulation and hemostasis (Fig EV4B) and
included several megakaryocyte/platelet genes (e.g., Vwf, Gp9, and
Pf4). By contrast, transcripts downregulated by uSTAT5 depletion
were enriched in genes involved in lymphocyte activation and dif-
ferentiation (Fig EV4C).
Approximately 32% (117 of 367) of upregulated transcripts and
31% (203 of 662) of downregulated transcripts were annotated to
uSTAT5 peaks, indicating that they represent direct uSTAT5 targets.
Altered expression was confirmed by quantitative RT–PCR for 6 of 6
direct target genes tested (Figs 3D and EV4D), including multiple
genes implicated in megakaryopoiesis. Moreover, those megakary-
ocytic genes (e.g., Mpl, Gp9, and Pf4) were also upregulated by TPO
stimulation (Fig 3E). The transcriptional response to TPO of
uSTAT5 targets was slower and more prolonged than that of canoni-
cal pSTAT5 targets (Fig 3E and F).
Together, these results reveal two distinct transcriptional
programs, both triggered by TPO and directly regulated by STAT5.
One is driven by pSTAT5 and includes canonical STAT target genes
that regulate processes including cell survival and proliferation
(e.g., Bcl-x and Pim1). The second was previously unrecognized
and is regulated by uSTAT5 which represses multiple megakary-
ocytic genes.
uSTAT5 inhibits megakaryocytic differentiation
Consistent with our gene expression data, uSTAT5 depletion
resulted in increased numbers of cells with megakaryocytic features
including increased size, expression of acetylcholinesterase (Fig 4A
and B), increased nuclear ploidy (Fig 4C), and increased expression
of CD41 and CD61 (Fig 4D). Importantly, these changes were
observed despite the continued presence of SCF and absence of
TPO, conditions that limit megakaryocytic differentiation. To exam-
ine the effects of increasing uSTAT5 levels on megakaryocyte dif-
ferentiation, we employed a STAT5B mutant (Y699F) that lacks the
key tyrosine phosphorylation site (Fig 4E and F). Compared to cells
infected with empty vector (EV) or WT, cells expressing the Y699F
mutant exhibited attenuated differentiation into megakaryocytes
(Fig 4G–I). We considered the possibility that the Y699F mutant
might act in a dominant negative manner to inhibit tyrosine phos-
phorylation or function of endogenous STAT5. However, pSTAT5
levels in cells expressing the Y699F mutant were similar to those in
control cells infected with empty vector (Fig 4F). Moreover, tran-
script levels of pSTAT5 target genes were not altered by expression
of the Y699F mutant, suggesting that Y694F did not affect the func-
tion of pSTAT5, including dimerization of pSTAT5 and/or pSTAT5
Figure 2. TPO stimulation results in genome-wide redistribution of STAT5.
A Summary of ChIP-Seq results obtained using HPC7 cells and an antibody to total STAT5. For each STAT5-occupied region, the occupancy of STAT5 in unstimulated
(T = 0 min) and in TPO-stimulated (T = 30 min) cells is indicated within a 5-kb window centered on the total STAT5-bound region.
B Examples of loci containing ChIP-Seq peaks from cluster 1 (i.e., uSTAT5 peaks) or cluster 2 (i.e., pSTAT5 peaks) showing the loss of the former and appearance of the
latter following TPO stimulation.
C, D ChIP-Seq results were validated by ChIP-qPCR using antibodies against total STAT5 or pSTAT5. Data represented as means  SD of three independent experiments.
Two-tailed Student’s t-test; **P < 0.01; ***P < 0.001.
E De novo motif discovery using MEME with STAT5-binding sites as input. The most significantly enriched motifs in unstimulated and TPO-treated HPC7 cells are
shown.
F Venn diagram showing the overlap between STAT5 and CTCF binding.
G ChIP-Seq genome browser views showing colocalization of uSTAT5 binding with CTCF.
H Immunofluorescence analysis of STAT5 wild-type and knockout MEFs with 40 ,6-diamidino-2-phenylindole (DAPI) staining (blue) and staining with anti-STAT5
antibody (red). Scale bars represent 25 lm.
I Western blot analysis of cell lysates isolated from STAT5 wild-type and knockout MEFs.
Source data are available online for this figure.
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Figure 3. uSTAT5 depletion activates a megakaryocytic transcriptional program.
A Western blot analysis showing an efficient knockdown of uSTAT5 in HPC7 cells on day 3 after infection.
B RNA-Seq analysis following uSTAT5 depletion by shRNA_7 in HPC7 cells grown in SCF. The 40 most upregulated genes following uSTAT5 knockdown are illustrated.
Genes upregulated during megakaryopoiesis are indicated in red.
C Gene set enrichment analysis showing a significant enrichment of a megakaryocyte progenitor (MKP, LinSca1Kit+Itga2b+Slamf1+) signature in STAT5-knockdown
cells. CLP, common lymphoid progenitor (LinSca1lowKitlowIL7r+Flk2+); pre-GM, pre-granulocyte/macrophage progenitors
(LinSca1Kit+Itga2bFcgRlowSlamf1Englow); NES, normalized enrichment score.
D Quantitative RT–PCR confirmed upregulation of uSTAT5 target genes following uSTAT5 depletion. Relative RNA levels were normalized to 18S rRNA. Bar graphs
represent means  SD of three independent experiments. Two-tailed Student’s t-test; *P < 0.05; **P < 0.01; ***P < 0.001.
E, F Kinetics of the upregulation of uSTAT5 (E) and pSTAT5 (F) target genes following TPO stimulation. Mean  SD; n = 3; two-tailed Student’s t-test; a significant
difference from time 0: *P < 0.05; **P < 0.01.
Source data are available online for this figure.
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binding to its target genes (Fig 4J, compare EV with Y699F),
whereas multiple uSTAT5 target genes were repressed following
introduction of the Y699F mutant (Fig 4K, compare EV with Y699F).
Our results therefore indicate that expression of the Y699F mutant
inhibited megakaryocytic differentiation by increasing uSTAT5
activity.
To extend these findings to primary cells, lentiviral shRNA
constructs were used to deplete STAT5 in mouse bone marrow
LSK cells (Fig EV5A). Consistent with our results using HPC7 cells,
the depletion of STAT5 was associated with enhanced megakary-
ocyte differentiation including an increased proportion of cells
expressing CD41/CD61 (Fig EV5B) and increased expression of
multiple megakaryocyte-affiliated genes (Fig EV5C). Conversely,
retroviral expression of the STAT5B Y699F mutant was accompa-
nied by attenuated megakaryocytic differentiation of LSK cells
grown in TPO (Fig EV5D and E) and reduced expression of multi-
ple megakaryocyte-affiliated genes (Fig EV5F). Together, these
knockdown and overexpression studies demonstrate that uSTAT5
inhibits megakaryocytic differentiation of hematopoietic stem and
progenitor cells.
uSTAT5 antagonizes ERG binding
Combinatorial binding of transcription factors provides a lineage-
specific regulatory code. We therefore hypothesized that uSTAT5
might modulate the megakaryocytic transcriptional program by
interacting with other transcription factors known to influence
megakaryopoiesis. Genome-wide binding of uSTAT5 was
compared with ChIP-Seq datasets, generated using HPC7 cells, for
10 key hematopoietic transcription factors (Wilson et al, 2010)
including 5 implicated in megakaryocytic differentiation (FLI1,
ERG, SCL, GATA2, and RUNX1). Clustering of the global occu-
pancy patterns revealed that uSTAT5 binding events were strongly
correlated with CTCF and also with ERG, Fli1, and SCL (Fig 5A).
Strikingly, approximately 75% of the sites bound by uSTAT5 and
CTCF were also occupied by ERG (Fig 5B and Appendix Fig S1A),
an ETS family transcription factor known to regulate hemato-
poietic stem cell self-renewal and megakaryopoiesis (Loughran
et al, 2008; Ng et al, 2011). Moreover, an ETS-binding motif was
the second most enriched motif within uSTAT5 peaks
(Appendix Table S1). Using the SPAMO program (Whitington
et al, 2011), we found that the CTCF and ETS motifs were
frequently separated by 7 bp (P = 8.3e-22; Appendix Fig S1B),
indicating a possible interaction between proteins binding to these
two sites.
To investigate whether ERG and uSTAT5 cooperate or compete
at shared target sites, ChIP-reChIP experiments were performed to
determine whether they bind to the same DNA molecules. Using
HPC7 cells grown in self-renewal conditions, chromatin regions
precipitated by an antibody to STAT5 were subsequently precipi-
tated by an antibody to CTCF, but not by one to ERG (Fig 5C).
Moreover, chromatin regions precipitated by an antibody to ERG
were subsequently precipitated by an antibody to CTCF, but not by
one to STAT5 (Fig 5D). These results indicate that the observed
colocalization reflects mutually exclusive binding of uSTAT5 and
ERG to a given CTCF-binding region. Consistent with this interpreta-
tion, the depletion of uSTAT5 by shRNA-mediated knockdown in
self-renewing HPC7 cells was accompanied by reduced uSTAT5
binding and concomitant increased ERG binding to target sites
within the Mpl and F2r loci (Fig 5E and F). There was no alteration
of ERG binding at the Med8 locus, an ERG target gene with no colo-
calization of STAT5 and ERG peaks (Appendix Fig S1C). Impor-
tantly, TPO stimulation of HPC7 cells also resulted in reduced
binding of uSTAT5 and increased recruitment of ERG at the Mpl and
F2r loci (Fig 5G and H). The TPO-induced reduction in uSTAT5
binding remained evident 24 h after TPO stimulation despite the fact
that pSTAT5 induction is much more transient (Fig 1D), indicating
that the loss of uSTAT5 is not rapidly reversible.
Taken together, these data indicate that prior to the addition of
TPO, uSTAT5 antagonizes ERG activity by restricting its access to
megakaryocytic target genes and that TPO-induced loss of uSTAT5
binding functions as a molecular switch (Fig 6).
Discussion
Here, we show for the first time that cytokine-mediated differentia-
tion reflects the loss of a uSTAT transcriptional program. Using a
tractable cellular system, which permits analysis of endogenous
uSTAT5 function in the absence of pSTAT5, we demonstrate the
Figure 4. uSTAT5 represses megakaryocytic differentiation.
A Schematic diagram of lentiviral uSTAT5 knockdown in HPC7 cells.
B Depletion of uSTAT5 was accompanied by the appearance of large cells that stain positively for acetylcholinesterase (AchE). Scrambled shRNA (scr), shSTAT5_5 (sh_5),
or shSTAT5_7 (sh_7). Scale bars represent 25 lm.
C Increased percentage of polyploid cells following uSTAT5 depletion.
D Increased percentage of cells expressing high levels of CD41 and CD61 following uSTAT5 depletion.
E Strategy for assessing the effect of increasing uSTAT5 on megakaryocytic differentiation of HPC7 cells.
F Western blot analysis of HPC7 cells expressing empty vector (EV), wild-type STAT5B (WT), or mutant STAT5B (Y699F). EV- and Y699F-expressing cells exhibit similar
levels of STAT5 phosphorylation following TPO treatment (100 ng/ml for 30 min).
G Expression of the Y699F mutant repressed the appearance of large cells that stained for acetylcholinesterase (AchE). Scale bars represent 25 lm.
H The Y699F mutant increased the percentage of polyploidy cells.
I The Y699F mutant increased the percentage of cells expressing high levels of CD41 and CD61.
J Quantitative RT–PCR showing that the Y699F mutant did not alter the induction of pSTAT5 target genes by endogenous pSTAT5 following TPO stimulation (100 ng/ml
for 30 min).
K Quantitative RT–PCR showing that the Y699F mutant repressed the induction of uSTAT5 target genes following TPO treatment.
Data information: Bar graphs represent mean  SD from three independent experiments. Two-tailed Student’s t-test; *P < 0.05; **P < 0.01; ***P < 0.001.
Source data are available online for this figure.
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Figure 5. uSTAT5 binding highly colocalizes with ERG binding.
A Heatmap showing hierarchical clustering of pairwise peak overlap of HPC7 ChIP-Seq data, red representing positive Pearson’s correlation coefficient values and
blue representing negative correlation coefficients.
B Examples of ChIP-Seq genome browser views showing colocalization of uSTAT5 binding with ERG.
C ChIP-reChIP experiment using HPC7 cells grown in SCF-containing media. An antibody to total STAT5 or control IgG was used for the first pull-down and an
antibody to CTCF or ERG was used for the second pull-down.
D ChIP-reChIP experiment using HPC7 cells grown in SCF-containing media. An antibody to ERG or control IgG was used for the first pull-down and an antibody to
CTCF or STAT5 was used for the second pull-down.
E–H ChIP-qPCR showing an increased enrichment of ERG binding sites at Mpl or F2r loci following STAT5 knockdown (E) or stimulation with TPO (G). ChIP-qPCR
showing decreased uSTAT5 binding at Mpl and F2r loci after STAT5 knockdown (F) or following TPO treatment (H).
Data information: All bar graphs represent mean  SD; n = 3; two-tailed Student’s t-test; *P < 0.05; **P < 0.01.
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existence of an uSTAT5 program which represses megakaryocyte-
affiliated genes and which is alleviated by TPO-stimulated phospho-
rylation of STAT5.
Two aspects of our results are of particular significance. Firstly,
they reveal a novel mechanism whereby a lineage-specific cytokine
modulates JAK/STAT signaling and thus triggers a lineage-affiliated
transcriptional program. uSTAT5 colocalizes with three mega-
karyocytic transcription factors (ERG, FLI1, and SCL) and, at mega-
karyocytic loci, TPO triggers a loss of uSTAT5 accompanied by
increased ERG recruitment. ERG and FLI1 have overlapping essen-
tial functions in the formation of megakaryocytes and platelets (Hart
et al, 2000; Loughran et al, 2008; Kruse et al, 2009) and play a
central role in the transcriptional network that regulates megakary-
opoiesis. Coordinate binding of a heptad of transcription factors (in-
cluding ERG and FLI1) has been demonstrated in HPC7 cells
(Wilson et al, 2010), and regions bound by the heptad, which
contained GATA and ETS sites, were associated with primed or low-
level expression of megakaryocytic genes in murine hematopoietic
stem/progenitor cells, with GATA2 replaced by GATA1 at a subset
of loci during megakaryocytic differentiation (Pimkin et al, 2014).
Interestingly, we did not identify GATA-binding sites in the vicinity
of uSTAT5 peaks, suggesting that the regulatory elements bound by
uSTAT5 are distinct from those previously shown to bind GATA1
and GATA2.
Secondly, we demonstrate that uSTAT5 unexpectedly colocalizes
with CTCF, thus revealing a potential link between JAK/STAT
signaling and nuclear topology. CTCF is an architectural protein that
mediates interactions between distant genomic sites, frequently in
collaboration with cohesin. As a consequence, it influences tran-
scription by modulating promoter–enhancer interactions (Ong &
Corces, 2014), transcriptional pausing (Stadhouders et al, 2012;
Paredes et al, 2013), and alternative splicing (Shukla et al, 2011).
Moreover, CTCF and cohesin play a key role in compartmentalizing
the genomes of higher eukaryotes into functional domains (Nora
et al, 2012; Seitan et al, 2013; Sofueva et al, 2013; Zuin et al, 2014).
It is not yet clear how uSTAT5 is recruited to a specific subset of
CTCF-binding sites. Co-immunoprecipitation studies using endoge-
nous or exogenous proteins did not identify an interaction between
uSTAT5 and CTCF (data not shown), and it therefore seems likely
that uSTAT5 is recruited by one of the multiple proteins known to
interact with CTCF (Ong & Corces, 2014).
Previously published STAT5 ChIP-Seq studies did not provide
deep sequencing data for the unstimulated condition. However
Hirahara et al (2015) recently reported binding profiles for STAT3
in unstimulated T cells, as well as T cells stimulated with IL-6 and
IL-27. Of note, they showed in their Fig 6A that over 900 peaks are
present in the unstimulated condition and go away with both IL-6
and IL-27 stimulation. The authors of this paper make no comment
about these peaks and do not investigate them further. In the
context of our paper, it seemed likely that at least some of these
peaks will correspond to binding by tyrosine-unphosphorylated
STAT3 and may therefore not show enrichment of the GAS STAT
consensus-binding site. To investigate this further, we downloaded
and reanalyzed their raw data. As already noted by Hirahara et al,
approximately 60% of STAT3-occupied regions showed no change
following IL-6 or IL-27 stimulation. The remaining peaks showed
dynamic changes in STAT3 occupancy (Appendix Fig S2).
Importantly, 902 peaks were specific to unstimulated cells
(Appendix Fig S2, cluster 4). Moreover, peaks specific to unstimu-
lated cells show much lower prevalence of the GAS motif than those
peaks appeared after cytokine stimulation. This analysis therefore is
consistent with uSTAT3 binding in primary hematopoietic cells and
suggests that our model applies to other Stat proteins in a different
cell lineage.
Our results also have broad implications for both normal hema-
topoiesis and the pathogenesis of leukemia. Hematopoietic stem/
progenitor cells are characterized by promiscuous expression of
genes affiliated to multiple lineages, a phenomenon termed lineage
priming (Cross & Enver, 1997; Enver & Greaves, 1998), and it has
recently been reported that a subset of hematopoietic stem cells is
primed to undergo megakaryocytic differentiation (Sanjuan-Pla
et al, 2013; Yamamoto et al, 2013). We demonstrate that uSTAT5
functions as a transcriptional switch, which mediates TPO-induced
upregulation of a poised megakaryocytic program. Multiple hemato-
logical malignancies harbor somatic mutations, which increase
JAK/STAT signaling (Chen et al, 2012; Vainchenker & Constanti-
nescu, 2013); our data indicate that expression of uSTAT5
target genes will be modulated by such mutations and are likely to
contribute to the neoplastic phenotype. Increased expression of ERG
causes myeloid leukemias in mice (Goldberg et al, 2013) and is
associated with poor outcome in human AML (Tursky et al, 2015);
genome-wide loss of uSTAT5 binding may therefore contribute to
the leukemogenic consequences of JAK/STAT activation by increas-
ing access of ETS factors to their target genes. Lastly, the discovery
of a uSTAT5 transcriptional program has major implications for the
development of therapeutic STAT5 inhibitors, most of which
currently target only pSTAT5 (Furqan et al, 2013).
Materials and Methods
Isolation of LSK cells
Bone marrow cells were collected from 6- to 12-week-old C57BL/6
mice. Lineage-positive cells were depleted by using EasySepTM
P
ERG 
CTCF ETS GAS 
+TPO 
CTCF STAT5 
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CTCF ETS GAS 
Megakaryocytic genes
Megakaryocytic genes
Canonical STAT target genes 
Canonical STAT target genes 
STAT5 
PCTCF 
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pSTAT5 program uSTAT5 program 
Figure 6. Tyrosine-unphosphorylated STAT5 represses a
thrombopoietin-inducible megakaryocytic transcriptional program.
Model illustrating the dual STAT5-mediated transcriptional consequences of TPO
stimulation: the loss of repression by uSTAT5 of a megakaryocytic program with
the concomitant activation of canonical pSTAT target genes.
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Mouse Hematopoietic Progenitor Cell Enrichment Kit (STEMCELL
Technologies). The remaining cells were stained with antibodies
against PE-conjugated Sca-1 and APC-cy7-conjugated c-Kit (eBio-
science) followed by fluorescence-activated cell sorter (FACS) purifi-
cation.
HPC7 cell culture
HPC7 cells were grown in IMDM (Gibco-Life Technologies) supple-
mented with 10% fetal calf serum (FBS), 10% SCF-conditioned
media, 1% L-glutamine, 1% penicillin/streptomycin, and 74.8 lM
MTG (Sigma) (Pinto do et al, 1998). For serum starvation and TPO
stimulation, cells were counted, spun down at 1,000 rpm for 5 min,
washed twice in PBS, resuspended at 1 × 106 cells/ml in StemSpan
SFEM (STEMCELL Technologies), and incubated for 4 h. To activate
STAT5, we used recombinant murine thrombopoietin (TPO,
Peprotech) at 100 ng/ml for 30 min unless indicated otherwise.
Megakaryocytic differentiation
HPC7 cells were resuspended at 5 × 105 cells/ml in CellGro media
(CellGenix) containing SCF (20 ng/ml) and TPO (100 ng/ml) for
2 days, and then SCF was removed, while TPO remained for an
additional 5 days (Dumon et al, 2012). For AchE staining, cells were
adhered to glass slides by cytospin and stained using AchE staining
kit (MBL International) according to the manufacturer’s instruction.
For ploidy analysis, cells were harvested and fixed with 70%
ethanol. The cells were washed twice with PBS and incubated in PI/
RNase staining buffer (BD Bioscience) containing 0.1% Triton X-100
for 45 min. The stained samples were analyzed immediately on
Cyan flow cytometer. CD41- and CD61-positive cells were deter-
mined by flow cytometry performed on Cyan flow cytometer and
analyzed using FlowJo software (Tree Star). Antibodies used were
FITC- or PB-conjugated CD41 and PE- or APC-conjugated CD61
(eBioscience).
FACS-sorted mouse bone marrow LSK cells (5 × 103 cells/ml)
were cultured in StemSpan SFEM (STEMCELL Technologies) supple-
mented with SCF (100 ng/ml) and TPO (100 ng/ml) for 2 days and
then in StemSpan SFEM supplemented with SCF (20 ng/ml) and
TPO (100 ng/ml) for additional 7 days.
Chromatin immunoprecipitation sequencing (ChIP-Seq)
Chromatin immunoprecipitation (ChIP) assays were performed as
previously described (Forsberg et al, 2000; Wilson et al, 2010) using
antibodies against total STAT5 (Santa Cruz, sc835), ERG (Santa
Cruz, sc354x), CTCF (Millipore, 07-592), and control rabbit IgG
(Invitrogen, 9172). ChIP DNA samples were amplified for sequenc-
ing with the Illumina Chip-Seq Sample Prep Kit (Illumina) and
sequenced with the Illumina GA2 Genome Analyser platform. The
ChIP-Seq data from this study have been submitted to the NCBI
Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/
geo/) under accession number GSE70697.
Immunofluorescence assay
One-third of FACS-sorted LSK cells were directly spun onto the glass
slides (freshly isolated). Remaining cells were attached to glass
slides by cytospin following incubation in StemSpan SFEM (STEM-
CELL Technologies) for 4 h (Starved) and subsequent TPO (100 ng/
ml) stimulation for 30 min (TPO treated). Staining for total STAT5
(Santa Cruz, sc835) and phospho-STAT5 (Cell Signaling, 9314) was
carried out after fixation and permeabilization. The cell nuclei were
counterstained with 40,6-diamidino-2-phenylindole (DAPI). To
quantify fluorescence, at least 10 fields were randomly selected and
quantified on image analyzer (Image J, NIH). Briefly, each nucleus
was outlined from thresholded images of the DAPI channel and this
was then superimposed onto the corresponding fluorescent image of
the same nucleus. In each nucleus, the average pixel intensity (API)
per unit area was calculated. The same outline of each nucleus cone
was then moved onto an adjacent empty region, and the API of this
background was calculated. The API of each background was
subtracted from the API of nucleus to calculate the corrected nuclear
API.
Western blotting
Whole-cell lysates were prepared by resuspending cells in modified
RIPA buffer and 2× Laemmli sample buffer (Bio-Rad). Protein
samples were separated by 8% SDS–PAGE and transferred to nitro-
cellulose membranes (Millipore). The membranes were blocked in
TBST containing 3% non-fat milk prior to incubation with primary
antibodies. Detection was performed with horseradish peroxidase
(HRP)-conjugated secondary antibody (BioRad) and enhanced by
chemiluminescence (ECL) reagent (Pierce). Image J software was
used to analyze the densitometry value of Western blots bands.
Cell fractionations
Nuclear and cytoplasmic fractions were prepared as previously
described (Osborn et al, 1989). Briefly, cells were washed twice
with PBS and once in Buffer A (10 mM HEPES pH 7.9, 1.5 mM
MgCl2, 10 mM KCl, 0.5 mM DTT and protease inhibitor cocktail).
Cells were then pelleted and resuspended in Buffer A with 0.1%
NP-40 and incubated on ice for 10 min. The supernatant containing
the cytoplasmic fraction was collected by centrifugation, and the
pellet was resuspended in an equal volume (relative to the cytoplas-
mic extract) of Buffer B (20 mM HEPES pH 7.9, 1.5 mM MgCl2,
300 mM NaCl, 0.5 mM DTT, 25% glycerol, 0.2 mM EDTA, and
protease inhibitor cocktail). To extract chromatin-bound proteins,
Pierce Universal Nuclease (Thermo Scientific) was added to the
nuclear lysate and incubated for 90 min on ice. Following centrifu-
gation, equal volumes of nuclear and cytoplasmic fractions were
analyzed by immunoblotting.
RNA-Seq and quantitative RT–PCR
HPC7 cells were infected with lentivirus containing shRNA specific
for STAT5. Scrambled shRNA was used as mock controls. Infected
cells were selected using puromycin (1 lg/ml) for 2 days and
recovered in IMDM supplemented with 10% FBS and 10% SCF-
conditioned media for 24 h. Total RNA was isolated using RNeasy
kit (Qiagen) and subjected to RNA sequencing (BGI). The gene
expression level was calculated by using RPKM method (Reads Per
kb per Million reads). DEseq packages (Wang et al, 2010) were used
for standardization and identification of differentially expressed
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genes (Anders & Huber, 2010). We defined the differentially
expressed genes that satisfy FDR <0.001 and fold change >1.5.
Lineage signatures were analyzed by GSEA (Subramanian et al,
2005) using published microarray data of different hematopoietic
progenitor cells (Pronk et al, 2007). For RT–PCR, total RNA was
reverse-transcribed into first-strand cDNA using SuperScriptIII First
Strand Synthesis Super Mix (Invitrogen) following the manufac-
turer’s instructions. Quantitative RT–PCR was carried out using
SYBR Green Brilliant II low Rox on Stratagene Mx3000P (Agilent
Technologies).
STAT5 retrovirus expression
Retrovirus was produced using the pCL-Eco Retrovirus Packaging
Vector (Imgenex). HPC7 cells were infected with retrovirus in the
presence of 8 lg/ml polybrene (Millipore). After 24 h, virus-infected
GFP-positive cells were FACS-sorted and cultured for another 48 h
in IMDM supplemented with 10% FBS and 10% SCF-conditioned
media before megakaryocyte differentiation.
STAT5 knockdown
Two independent lentiviral shRNAs (TRCN0000012553 and
TRCN0000012557) were used to knockdown STAT5B protein. Lenti-
virus was produced by transfecting 293T cells with 7 lg/ml STAT5
shRNA plasmids, 5 lg/ml psPAX2, and 2 lg/ml pMD2.G. Forty-
eight hours after 293T cell transfection, supernatant containing
lentivirus was collected and concentrated using Lenti-X concentrator
(Clontech). For infection, 100 ll of concentrated lentivirus was
added to each well of a 6-well plate containing 1 × 105 cells. Cells
were incubated with lentivirus for 24 h and subjected to puromycin
selection (1–2 lg/ml) for 2 days. Control cells were infected with
lentivirus containing scrambled shRNA. Quantification of the
Western blot images with Image J showed the STAT5-knockdown
efficiency in HPC7 cells is higher than 95% at protein level.
Statistical analysis
The results are presented as means  SD. Experimental data were
analyzed using two-tailed Student’s t-test. P-values less than 0.05
were considered statistically significant.
ChIP-Seq analysis
Peak calling and heatmap
Significant binding events in comparison with a control IgG sample
were found using MACS (Zhang et al, 2008). Peak coordinates in
regions with high repeat content were subtracted from the list of
high confidence peak coordinates. All peaks were standardized to
400 bp based on MACS summits. The heatmap was generated in R
using the heatmap.2 function of the gplots package, with hierarchi-
cal clustering using the “ward” method. Colors were generated
using the package RColorBrewer.
Motif analysis
De novo motif finding analysis was conducted with MEME (Bailey
et al, 2009) using standard settings. We used the sequences of
100 bp around the peak summit as input for the motif discovery.
Peaks containing more than 40% of repetitive sequences were
excluded from the analysis. Matches to consensus sequences were
determined using TOMTOM (Gupta et al, 2007).
Central motif enrichment analysis (CMEA) was performed using
CentriMo (Bailey & Machanick, 2012). This algorithm has been
developed based on the observation that the direct TF (transcription
factor) binding sites tend to cluster near the center of any ChIP-ed
regions.
Gene mapping
Peaks were mapped to the nearest gene first considering those
whose promoter overlapped the peak, then those genes directly
overlapping peaks in other regions, and then any gene within 50 kb
on both directions of the peak coordinates (simultaneous presence
of genes on both the 50 and 30 flanking window was resolved consid-
ering both genes). We used gene coordinates as defined by UCSC
and promoter as defined on the mammalian promoter database
(MPromDB).
Expanded View for this article is available online.
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